First Day Children’s Multivitamin Needs ‘Good Fit’ Studies To Support Hyperactivity Claims
Executive Summary
First Day Life discontinues claims its children’s multivitamin could help with attention issues and hyperactivity during a review by the National Advertising Division, which reminded the firm that studies in support of claims must not only be competent and reliable but also a “good fit.”
You may also be interested in...
CRN Ends Funding For Industry Self-Regulation Program Focused On Supplement Advertising
The trade group ends funding for National Advertising Division program launched in 2006 for increased focus on monitoring supplement claims, reviewing 360 in total. Separately, NAD launches an expedited challenge process aiming to conclude reviews in 20 business days.
Claim That Supplement Boosts Children’s Focus Could Spur FTC Attention
Creekside Natural Therapeutics might hear from the FTC after failing to show in an industry self-regulation forum that it would correct misleading claims for its Focused Mind Jr. supplement promoted as an alternative to ADHD drugs.
FDA Keeps Door Open To Help Observational Studies Work For Health Claims
FDA says in a final guidance that observational studies alone are insufficient support for health claims, but the agency also says it is interested in making it easier for those studies to support claims